Manuel Litchman
Director Ejecutivo en MUSTANG BIO, INC. .
Fortuna: 44 738 $ al 30/04/2024
Cargos activos de Manuel Litchman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MUSTANG BIO, INC. | Director/Miembro de la Junta | 24/04/2017 | - |
| Director Ejecutivo | 24/04/2017 | - | |
| Presidente | 24/04/2017 | - | |
| Director Financiero/CFO | 11/12/2023 | 19/01/2024 |
Historial de carrera de Manuel Litchman
Antiguos cargos conocidos de Manuel Litchman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/08/2012 | 01/12/2014 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Director/Miembro de la Junta | 12/01/2015 | - |
| Director Ejecutivo | 12/01/2015 | - | |
| Presidente | 12/01/2015 | - |
Formación de Manuel Litchman.
| Princeton University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Suiza | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MUSTANG BIO, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Manuel Litchman
- Experiencia
